Alembic Pharmaceuticals Limited (APLLTD) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.076x

Based on the latest financial reports, Alembic Pharmaceuticals Limited (APLLTD) has a cash flow conversion efficiency ratio of 0.076x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs4.03 Billion ≈ $43.57 Million USD) by net assets (Rs53.16 Billion ≈ $574.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Alembic Pharmaceuticals Limited (APLLTD) net asset quality to measure how much of total assets are equity-financed.

Alembic Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Alembic Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Alembic Pharmaceuticals Limited cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Alembic Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alembic Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tibet Mineral Development Co Ltd SHE:000762	0.009x
Eugene Technology Co.Ltd KQ:084370	0.021x
BaoViet Holdings VN:BVH	-0.103x
Jiangxi Lianchuang Opto-electronic Science & Technology Co Ltd SHG:600363	0.012x
Xizi Clean Energy Equipment Manufacturing Co Ltd SHE:002534	0.028x
Nava Bharat Ventures Limited NSE:NAVA	0.158x
Addus HomeCare Corporation NASDAQ:ADUS	0.047x
Melco Resorts & Entertainment Limited F:MAS	0.355x

Annual Cash Flow Conversion Efficiency for Alembic Pharmaceuticals Limited (2011–2025)

The table below shows the annual cash flow conversion efficiency of Alembic Pharmaceuticals Limited from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see APLLTD company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs51.90 Billion ≈ $561.23 Million	Rs879.70 Million ≈ $9.51 Million	0.017x	-89.83%
2024-03-31	Rs48.18 Billion ≈ $521.07 Million	Rs8.03 Billion ≈ $86.86 Million	0.167x	+0.64%
2023-03-31	Rs43.70 Billion ≈ $472.65 Million	Rs7.24 Billion ≈ $78.29 Million	0.166x	+57.07%
2022-03-31	Rs52.38 Billion ≈ $566.42 Million	Rs5.52 Billion ≈ $59.73 Million	0.105x	-63.48%
2021-03-31	Rs50.67 Billion ≈ $547.97 Million	Rs14.63 Billion ≈ $158.26 Million	0.289x	+105.16%
2020-03-31	Rs31.90 Billion ≈ $345.04 Million	Rs4.49 Billion ≈ $48.57 Million	0.141x	-52.88%
2019-03-31	Rs27.18 Billion ≈ $293.94 Million	Rs8.12 Billion ≈ $87.81 Million	0.299x	+112.32%
2018-03-31	Rs22.20 Billion ≈ $240.13 Million	Rs3.12 Billion ≈ $33.79 Million	0.141x	-7.37%
2017-03-31	Rs19.01 Billion ≈ $205.61 Million	Rs2.89 Billion ≈ $31.23 Million	0.152x	-73.87%
2016-03-31	Rs16.01 Billion ≈ $173.09 Million	Rs9.30 Billion ≈ $100.62 Million	0.581x	+199.39%
2015-03-31	Rs8.85 Billion ≈ $95.67 Million	Rs1.72 Billion ≈ $18.58 Million	0.194x	-44.47%
2014-03-31	Rs6.76 Billion ≈ $73.06 Million	Rs2.36 Billion ≈ $25.55 Million	0.350x	-33.59%
2013-03-31	Rs5.03 Billion ≈ $54.39 Million	Rs2.65 Billion ≈ $28.64 Million	0.527x	+47.78%
2012-03-31	Rs3.95 Billion ≈ $42.72 Million	Rs1.41 Billion ≈ $15.22 Million	0.356x	+9.39%
2011-03-31	Rs2.95 Billion ≈ $31.93 Million	Rs961.81 Million ≈ $10.40 Million	0.326x	--

About Alembic Pharmaceuticals Limited

NSE:APLLTD India Drug Manufacturers - Specialty & Generic

Market Cap

$1.69 Billion

Rs156.67 Billion INR

Market Cap Rank

#6649 Global

#318 in India

Share Price

Rs797.05

Change (1 day)

-1.84%

52-Week Range

Rs646.55 - Rs992.95

All Time High

Rs1247.70